Although she had no laboratory signs of chronic hepatitis (HBsAg weakly positive 40 IU/mL, HBV DNA undetectable, normal ALT) at the time of assessment, thereby formally not meeting the criteria for antiviral therapy according to the EASL guidelines, antiviral therapy was recommended. The gene discussed is GPT; the disease is chronic hepatitis.